4.5 Review

Therapeutic modulation of miRNA for the treatment of proinflammatory lung diseases

Journal

EXPERT REVIEW OF ANTI-INFECTIVE THERAPY
Volume 10, Issue 3, Pages 359-368

Publisher

TAYLOR & FRANCIS LTD
DOI: 10.1586/ERI.11.175

Keywords

anti-miRs; asthma; cystic fibrosis; innate immunity; miR inhibitors; miRNA; miRNA therapeutics; Toll-like receptors

Funding

  1. Health Research Board in Ireland [PHD/2007/11]
  2. Irish Drug Delivery Network (IDDN) [SFI 07/SRC/B1154]
  3. HRB [RP2005/117]

Ask authors/readers for more resources

miRNAs are short, nonprotein coding RNAs that regulate target gene expression principally by causing translational repression and/or mRNA degradation. miRNAs are involved in most mammalian biological processes and have pivotal roles in controlling the expression of factors involved in basal and stimulus-induced signaling pathways. Considering their central role in the regulation of gene expression, miRNAs represent therapeutic drug targets. Here we describe how miRNAs are involved in the regulation of aspects of innate immunity and inflammation, what happens when this goes awry, such as in the chronic inflammatory lung diseases cystic fibrosis and asthma, and discuss the current state-of-the-art miRNA-targeted therapeutics.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available